EBV-positive PEL-like lymphoma that developed in the course of antisynthetase syndrome treated with tacrolimus.

We describe a case of PEL-like lymphoma that developed in the course of antisynthetase syndrome and was treated with tacrolimus. A single dose of systemic chemotherapy did not improve lymphomatous effusion, whereas the discontinuation of tacrolimus resulted in the long-term remission of this disease. PMID: 29516290 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29516290?dopt=Abstract

Source: International Journal of Hematology - March 7, 2018 Category: Hematology Authors: Okada K, Asakura S, Yano T, Kishimoto T Tags: Int J Hematol Source Type: research